SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-17-185543
Filing Date
2017-05-26
Accepted
2017-05-26 16:09:16
Documents
16
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d377168d10ka.htm 10-K/A 26551
2 EX-2.4 d377168dex24.htm EX-2.4 844558
3 EX-10.61 d377168dex1061.htm EX-10.61 375575
4 EX-10.62 d377168dex1062.htm EX-10.62 1725370
5 EX-10.68 d377168dex1068.htm EX-10.68 515541
6 EX-31.3 d377168dex313.htm EX-31.3 3560
7 EX-31.4 d377168dex314.htm EX-31.4 3559
8 GRAPHIC g377168g0523104509472.jpg GRAPHIC 43250
9 GRAPHIC g377168g0523104509674.jpg GRAPHIC 45517
10 GRAPHIC g377168g0523104509940.jpg GRAPHIC 41302
11 GRAPHIC g377168g0523104510064.jpg GRAPHIC 4358
12 GRAPHIC g377168g0523113920044.jpg GRAPHIC 4858
13 GRAPHIC g377168g78w48.jpg GRAPHIC 6971
14 GRAPHIC g377168img.jpg GRAPHIC 11635
15 GRAPHIC g377168img22.jpg GRAPHIC 20755
16 GRAPHIC g377168ir.jpg GRAPHIC 7089
  Complete submission text file 0001193125-17-185543.txt   3752852
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35238 | Film No.: 17874042
SIC: 2834 Pharmaceutical Preparations